Annovis Bio Inc (NY: ANVS )

22.02 +0.20 (+0.94%)

Streaming Delayed Price Updated: 1:26 PM EDT, Apr 22, 2021 Add to My Watchlist

Price and Volume

Volume	60,289
Open	21.54
Bid (Size)	22.08 (2)
Ask (Size)	22.28 (1)
Prev. Close	21.82
Today's Range	21.02 - 22.78
52wk Range	3.330 - 47.99
Shares Outstanding	6,946,904
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Annovis Bio Appoints Reid McCarthy to Board and to Role of Audit Committee Chairman

April 15, 2021

Annovis Bio Presenting at M Vest and Maxim Group Inaugural Emerging Growth Virtual Conference

March 17, 2021

Performance

YTD	+170.25%	+170.25%
1 Month	-37.96%	-37.96%
3 Month	+120.69%	+120.69%
6 Month	+362.71%	+362.71%
1 Year	+479.61%	+479.61%

More News

Best Stocks To Buy Today? 4 Biotech Stocks To Know

March 19, 2021

Annovis Bio Announces Positive Phase 2 Data - Interim Data Shows ANVS401 Improves Speed and Coordination in Parkinson's Patients

March 16, 2021

Biotech Stocks To Buy In March 2021? 4 Names To Know

March 16, 2021

Annovis Bio Signs GMP Manufacturing Agreement to Support Planned Late- Stage Studies

March 11, 2021

Annovis Bio Receives Japanese Patent for the Treatment of Acute Brain or Nerve Injury

March 10, 2021

Annovis Bio to Present at the H.C. Wainwright Global Life Sciences Conference

March 09, 2021

Annovis Bio Receives European Patent for Method of Treating Acute Nerve and Brain Insults

February 04, 2021

Annovis Bio Presents Novel Treatment For Alzheimer's And Parkinson's Diseases

March 18, 2021

Annovis Bio Stock Is Trading Higher After Parkinson's Med Shows Improvement In Speed, Coordination

March 16, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.